Journal of Cataract & Refractive Surgery · 2003 · 72 citations · 14 references
MedicineOphthalmologyPharmacologyOcular DiseaseOcular PharmacologyOphthalmic SurgeryImmunopathology Of The EyeMedication Effects On VisionOcular Cytokine BiologyOcular InflammationTopical Ophthalmic MedicationsAntiglaucoma Eye DropsAntiglaucoma TherapyDrug-induced Ocular IrritationDrug-induced Ocular ToxicityPreservative AgentsPreservative EffectivenessPreservatives In Eye FormulationsTopical Ocular Medication Toxicity
Many antiglaucoma eyedrops are reported to cause cystoid macular edema (CME) in aphakia and pseudophakia. We review 4 clinical and laboratory studies that compare the incidence of CME in early postoperative pseudophakia in eyes that received preserved latanoprost and timolol, nonpreserved timolol, and the preserved and nonpreserved vehicle for these drugs and looked at the morphological damage to cells and the changes in the indicators of cytokine and prostaglandin (PG) synthesis caused by latanoprost and timolol and the preservative benzalkonium chloride. Based on the findings of these studies, which indicate that the preservative causes increased synthesis of PGs and other substances and intensified postoperative inflammation, the term pseudophakic preservative maculopathy is proposed for CME caused by antiglaucoma eyedrops.
14
Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment
Archives of Ophthalmology · 1990 · 1K citations
Medicine, Ophthalmology, Surgery +14
Anterior uveitis associated with latanoprost
Robert D. Fechtner, Albert S Khouri, Thom J. Zimmerman et al. · American Journal of Ophthalmology · 1998 · 167 citations
Medicine, Ophthalmology, Surgery +12
Sayoko E. Moroi, María Soffía Gottfreðsdóttir, Miriam T Schteingart et al. · Ophthalmology · 1999 · 138 citations